Table 2.
The antibacterial activity (ZOI; mm ± SD) of the synthesized nanomaterials against the different six pathogenic bacteria; SD (standard deviation)
| Sample name | Zone of Inhibition (ZOI) (mm) Each value is Mean ± SD (n = 3) |
|||||
|---|---|---|---|---|---|---|
| Bacillus subtilus | Serratia sp. | MRSA | Streptococcus mutans | Staphylococcus aureus | Escherichia coli | |
| CeO2 MW/O.e | 30.0 ± 1.0 | 20.0 ± 1.0 | 29.0 ± 1.2 | 20.0 ± 1.5 | 27.0 ± 1.0 | 28.0 ± 1.0 |
| CeO2 MW/H2O | 25.7 ± 0.6 | 21.0 ± 1.0 | 10.0 ± 1.0 | 19.7 ± 1.2 | 17.0 ± 1.0 | 15.0 ± 1.0 |
| CeO2 H /O.e | 20.0 ± 1.0 | 20.0 ± 1.0 | 19.0 ± 1.0 | 20.7 ± 1.5 | 26.0 ± 1.0 | 29.0 ± 1.0 |
| CeO2 H /H2O | 10.0 ± 1.0 | 21.0 ± 1.0 | 10.3 ± 0.6 | 19.3 ± 0.6 | 11.0 ± 1.0 | 11.3 ± 0.6 |
| ZnO MW/O.e | 30.0 ± 1.0 | 29.0 ± 1.0 | 37.7 ± 0.6 | 41.0 ± 1.0 | 30.0 ± 1.0 | 31.0 ± 1.0 |
| ZnO MW/H2O | 25.7 ± 0.6 | 19.0 ± 1.0 | 35.3 ± 0.6 | 41.0 ± 1.0 | 20.0 ± 1.0 | 16.7 ± 0.6 |
| ZnO H /O.e | 15.0 ± 1.0 | 16.0 ± 1.0 | 30.3 ± 1.2 | 39.0 ± 1.0 | 30.0 ± 1.0 | 11.3 ± 0.6 |
| ZnO H /H2O | 11.0 ± 1.0 | 10.0 ± 1.0 | 30.0 ± 1.0 | 30.0 ± 1.0 | 19.0 ± 1.0 | 12.0 ± 1.0 |
| Flucloxacillin | 11.0 ± 1.0 | 20.0 ± 1.0 | 16.3 ± 0.6 | 12.0 ± 1.0 | 18.3 ± 0.6 | 18.0 ± 1.0 |
| Amoxicillin | 20.0 ± 1.0 | 15.3 ± 0.6 | 20.3 ± 1.5 | 19.0 ± 1.0 | 20.7 ± 0.6 | 21.3 ± 0.6 |